SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Value and cost‐effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window‐phase human immunodeficiency virus type 1 infections
11 references·5 citing·41 second hop
Value and cost‐effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window‐phase human immunodeficiency virus type 1 infections (1997)Value and cost‐effectiveness of screening…Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood (1997)Cost‐effectiveness of expande…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests (1995)Post-transfusion hepatitis: i…Infectious Disease Testing for Blood Transfusions (1995)Infectious Disease Testing fo…Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Estimated Risk of Transmissio…Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)Declining value of alanine am…Collection and transfusion of blood and blood components in the United States, 1992 (1995)Collection and transfusion of…Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion (1985)Measures to decrease the risk…Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion Recipients (1984)Hepatitis B Virus Antibody in…The Markov Process in Medical Prognosis (1983)The Markov Process in Medical…Clinical Decision Analysis (1980)Clinical Decision AnalysisUses and sources of data on long-term survival after blood transfusion (2003)Uses and sources of data on l…Economics of Transfusion (2002)Economics of Transfusion[Risk of transfusional-transmitted infections]. (2002)[Risk of transfusional-transm…Equity and the economic evaluation of healthcare (2001)Equity and the economic evalu…Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis (1999)Population based cost utility…Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Collection and transfusion of blood and blood components in the United States, 1994 (1998)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Anarchy, State, and Utopia (1975)Cost-Effectiveness in Health and Medicine (1996)Quality of Systematic Reviews of Economic Evaluations in Health Care (2002)QALYs and the capability approach (2005)The use of economic evaluations in NHS decision-making: a review and empirical investigation (2008)Anarchy, State, and Utopia (2018)Calculation of Polychotomous Logistic Regression Parameters Using Individualized Regressions (1984)Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood (1986)The Risk of Transfusion-Transmitted Infection (1992)Genomic screening for blood-borne viruses in transfusion settings (2000)Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT (2002)Emerging Infectious Threats to the Blood Supply (2004)Donor Transaminase and Recipient Hepatitis (1981)EVALUATING THE COST-EFFECTIVENESS OF CLINICAL AND PUBLIC HEALTH MEASURES (1998)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Preference-Based Measures in Economic Evaluation in Health Care (2000)Clinical decision analysis (2005)Intransitivity of preferences. (1969)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Utility approach to measuring health-related quality of life (1987)Utilities and Quality-Adjusted Life Years (1989)Collection and Transfusion of Blood in the United States, 1982–1988 (1990)Blood collection and transfusion in the United States in 2001 (2007)The United States' potential blood donor pool: estimating the prevalence of donor‐exclusion factors on the pool of potential donors (2007)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)A Population Study. (1975)A convenient approximation of life expectancy (the “DEALE”) (1982)The Beaver Dam Health Outcomes study (1993)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012)A review and critique of modelling in prioritising and designing screening programmes (2007)Transfusion-Associated Hepatitis and AIDS (1987)Public health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C (1991)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 1980Clinical Decision Analysis1,415 cited
  • 1983The Markov Process in Medical Prognosis957 cited
  • 1995Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States346 cited
  • 1984Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion Recipients302 cited
  • 1995Collection and transfusion of blood and blood components in the United States, 1992213 cited
  • 1997Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood130 cited
  • 1995Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study124 cited
  • 1995Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests91 cited
  • 1985Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion76 cited
  • 1995Infectious Disease Testing for Blood Transfusions74 cited

Cited by

  • 2001Equity and the economic evaluation of healthcare141 cited
  • 1999Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis85 cited
  • 2002

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

[Risk of transfusional-transmitted infections].
13 cited
  • 2003Uses and sources of data on long-term survival after blood transfusion11 cited
  • 2002Economics of Transfusion8 cited